Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter 2020 Intercept Pharmaceuticals Earnings Call. [Operator Instructions]
I'd now like to hand the conference over to your host today, Ms. Lisa DeFrancesco, Senior Vice President, Investor Relations and Corporate Affairs. Please go ahead.
Lisa DeFrancesco --
Senior Vice President, Corporate Affairs & Investor Relations
Thank you. Good morning, and thank you for joining us on today's call. This morning we issued a press release announcing our fourth quarter and full year 2020 results and financial position, which is available on our website at www.interceptpharma.com.
Before we begin our discussion, I'd like to note that during the call we will be making forward-looking statements, including statements regarding our approved products and clinical development program, certain regulatory matters and our strategy, prospects, financial guidance and future, commercial and financial performance. Listeners are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this call, and we undertake no obligation to update such statements except as required by law.